Data shows orforglipron could in future avoid need to take other long-term medications for diseases associated with obesity
A daily pill could help people keep weight off and stop them needing other long-term medications, scientists behind landmark new trial data have suggested.
The researchers said orforglipron could help prevent more than 200 diseases associated with obesity and could be prescribed to prevent lower levels of overweight tipping into obesity.
A large-scale randomised controlled trial found that patients using injectable GLP1s could maintain most of their weight loss if they switched to far cheaper daily pills.
About 30% of adults in the UK are living with obesity, with those on Wegovy or Mounjaro taking about seven medications for other health conditions.
